Skip to main content
Chimeric Therapeutics Limited (ASX:CHM)
Australia flag Australia · Delayed Price · Currency is AUD
0.0050
0.00 (0.00%)
Apr 24, 2025, 3:06 PM AEST

Chimeric Therapeutics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Net Income
-17.83-12.53-25.92-15.9-15.11-0.15
Depreciation & Amortization
1.571.080.970.950.85-
Loss (Gain) From Sale of Assets
0.010.0100--
Asset Writedown & Restructuring Costs
1.261.26----
Stock-Based Compensation
0.890.893.323.172.1-
Other Operating Activities
70.151.470.841-
Change in Accounts Receivable
3.563.56-0.99-2.63-0.02-
Change in Accounts Payable
-1.98-1.984.740.322.590.07
Change in Other Net Operating Assets
0.010.010.10.1-0.23-
Operating Cash Flow
-5.51-7.54-16.31-13.15-8.83-0.08
Capital Expenditures
----0.01-0.02-
Sale (Purchase) of Intangibles
---0.11-0.53-5.29-
Investment in Securities
----0.04--
Investing Cash Flow
0--0.11-0.58-5.31-
Short-Term Debt Issued
----0.86-
Total Debt Issued
1.56---0.860.08
Short-Term Debt Repaid
-----0.89-
Long-Term Debt Repaid
--2.28-2.23-4.05--
Total Debt Repaid
-3.01-2.28-2.23-4.05-0.89-
Net Debt Issued (Repaid)
-1.45-2.28-2.23-4.05-0.030.08
Issuance of Common Stock
9.1711.742.5814.939.30
Other Financing Activities
-0.74-1.21-0.1-1.31-2.72-
Financing Cash Flow
6.988.260.259.5436.540.08
Foreign Exchange Rate Adjustments
0.07-0.030.150.160.01-
Net Cash Flow
1.540.69-16.02-4.0322.410
Free Cash Flow
-5.51-7.54-16.31-13.17-8.85-0.08
Free Cash Flow Margin
-269.73%-101.07%-361.89%-503.04%--
Free Cash Flow Per Share
-0.01-0.01-0.04-0.04-0.05-
Cash Interest Paid
0.010.010.01-0.01-
Cash Income Tax Paid
--7.34-3.5---
Levered Free Cash Flow
0-4.3-10.45-6.8-4.57-
Unlevered Free Cash Flow
0.06-4.09-9.97-6.4-4.57-
Change in Net Working Capital
-8.58-2.22-1.470.87-7.07-
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.